Ignite Creation Date:
2024-05-05 @ 5:11 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00405743
Status:
COMPLETED
Last Update Posted:
2013-09-18
First Post:
2006-11-29
Brief Title:
A Phase III Study of CP-4055 in Patients With RefractoryRelapsed Hematologic Malignancies
Sponsor:
Clavis Pharma
Organization:
Clavis Pharma
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-05
Start Date Type:
None
Primary Completion Date:
2009-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-05
Completion Date Type:
ACTUAL
First Submit Date:
2006-11-29
First Submit QC Date:
November 29 2006
Study First Post Date:
2006-11-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2013-09-12
Disp First Submit QC Date:
September 12 2013
Disp First Post Date:
2013-09-18
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2013-09-12
Last Update Post Date:
2013-09-18
Last Update Post Date Type:
ESTIMATED